Creative Financial Designs Inc Castle Biosciences Inc Transaction History

Creative Financial Designs Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$18.08 - $30.0 $903 - $1,500	-50 Reduced 20.0%	200 $4,000
Q3 2022 Nov 01, 2022	SELL	$22.51 - $34.32 $7,878 - $12,012	-350 Reduced 58.33%	250 $7,000
Q2 2022 Aug 01, 2022	BUY	$16.0 - $45.99 $1,600 - $4,599	100 Added 20.0%	600 $13,000
Q3 2021 Oct 08, 2021	SELL	$60.13 - $77.6 $69,029 - $89,084	-1,148 Reduced 69.66%	500 $33,000
Q1 2021 Apr 19, 2021	SELL	$58.92 - $97.33 $19,090 - $31,534	-324 Reduced 16.43%	1,648 $113,000
Q4 2020 Jan 08, 2021	BUY	$43.6 - $73.05 $85,979 - $144,054	1,972 New	1,972 $132,000

201

24.5M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $656M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

Stay updated on Creative Financial Designs Inc with notifications on news.